date,title,source
Oct-30-18,Leading BioSciences Announces Appointments of James R. Neal and James Sapirstein to Board of Directors,GlobeNewswire
Oct-30-18,ContraVir Pharmaceuticals Completes Final Cohort Dosing in CRV431 Drug-Drug Interaction Study,GlobeNewswire
Nov-27-18,ContraVir Pharmaceuticals to Present CRV431 Preclinical Data at the Anti-Fibrotic Drug Development Summit,GlobeNewswire
